AG Sessions questions cannabis regulatory efficacy in CO, WA

U.S. Attorney General Jeff Sessions has contacted the governors of Colorado and Washington state and, using parallel language, questioned the effectiveness of state regulations designed to comply with the 2013 Cole Memo.

In letters to Colorado Gov. John Hickenlooper and Washington state Gov. Jay Inslee, Sessions referenced reports from the High Intensity Drug Trafficking Area (HIDTA), which compiled information in 2016 about general effects of cannabis legalization in both states, the Denver Post reported.

The attorney general suggested the first two recreational marijuana states haven’t done an adequate job of controlling cannabis production.

“This report raises serious questions about the efficacy of marijuana ‘regulatory structures’ in your state,” Sessions wrote separately to Hickenlooper and Inslee.

Sessions further asked for recommendations from both governors on how to address findings in the reports, including ongoing diversion to the black market, an increase in cannabis use by minors in both states and marijuana-related traffic deaths.

Sessions also noted in both letters, however, that the Department of Justice retains the authority to enforce federal law, a not-so-subtle reminder that he has the power to instigate a widespread crackdown on legal cannabis businesses.

Daily News | Briefs | Colorado Medical Cannabis Business & Marijuana Legal News | Legal & Regulatory News for Marijuana Businesses | Recreational Marijuana News | Washington State Medical Cannabis Business & Marijuana Legal News

 6 Comments

  1. If only... August 7, 2017
    • Robert Hunt August 7, 2017
  2. john h davis August 7, 2017
  3. Mike August 7, 2017
  4. Sonny August 8, 2017
  5. Morgan August 8, 2017

Leave a Reply

Your email address will not be published. Required fields are marked *

Please note: Comments are moderated by our editors who do their best to approve comments ASAP. As Marijuana Business Daily is focused on business, we approve comments that are specifically relevant to industry professionals. General opinions and questions about cannabis may not be posted.